Fellow
Memorial Sloan Kettering Cancer Center
Dr. Andrew Katims, MD, MPH, is a urologic oncology fellow at Memorial Sloan Kettering Cancer Center. He completed his undergraduate education at Washington University in St. Louis where he majored in environmental and evolutionary biology and minored in writing. He then attended the University of Miami Miller School of Medicine where he earned a joint MD/MPH degree. His primary public health interest was utilizing a biomarker as a screening test for a specific, high risk cancer population. Dr. Katims completed his urology residency training at the Icahn School of Medicine at Mount Sinai in New York and is now a urologic oncology fellow at Memorial Sloan Kettering Cancer Center. As a fellow, Dr. Katims has pursued translational research on urothelial cell carcinoma. His research focus is on developing non-invasive biomarkers that can reduce the burden of invasive procedures required for the diagnosis and surveillance of urothelial carcinoma. Ultimately, Dr. Katims’ goal is to utilize his translational research findings to inform clinical trials on targeted therapies, allow for early detection of disease and recurrence, and reduce the number of unnecessary procedures and surgeries that patients must face.
Disclosure information not submitted.
Sunday, April 30, 2023
3:30 PM – 5:30 PM CST